MedTrace Logo

Study of Safety and Efficacy of Diractin® for the Treatment of Osteoarthritis (OA) of the Knee

NCT00722852 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 555

Last updated 2009-10-05

No results posted yet for this study

Summary

The purpose of this study is to provide replicated evidence of safety and efficacy of 100 mg ketoprofen in Diractin®.

Conditions

  • Osteoarthritis of the Knee

Interventions

DRUG

ketoprofen in Diractin®

100 mg (b.i.d.)

DRUG

Placebo

100 mg (b.i.d.)

Sponsors & Collaborators

  • IDEA AG

    lead INDUSTRY

Principal Investigators

  • IDEA AG · IDEA AG

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
46 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2009-02-28
Completion
2009-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00722852 on ClinicalTrials.gov